236 related articles for article (PubMed ID: 10926371)
21. Hypochlorite-modified low-density lipoprotein stimulates human polymorphonuclear leukocytes for enhanced production of reactive oxygen metabolites, enzyme secretion, and adhesion to endothelial cells.
Kopprasch S; Leonhardt W; Pietzsch J; Kühne H
Atherosclerosis; 1998 Feb; 136(2):315-24. PubMed ID: 9543103
[TBL] [Abstract][Full Text] [Related]
22. 2-chlorohexadecanal derived from hypochlorite-modified high-density lipoprotein-associated plasmalogen is a natural inhibitor of endothelial nitric oxide biosynthesis.
Marsche G; Heller R; Fauler G; Kovacevic A; Nuszkowski A; Graier W; Sattler W; Malle E
Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2302-6. PubMed ID: 15514213
[TBL] [Abstract][Full Text] [Related]
23. Copper ions and hydrogen peroxide form hypochlorite from NaCl thereby mimicking myeloperoxidase.
Frenkel K; Blum F; Troll W
J Cell Biochem; 1986; 30(3):181-93. PubMed ID: 3009503
[TBL] [Abstract][Full Text] [Related]
24. Human low density lipoprotein as a target of hypochlorite generated by myeloperoxidase.
Jerlich A; Fabjan JS; Tschabuschnig S; Smirnova AV; Horakova L; Hayn M; Auer H; Guttenberger H; Leis HJ; Tatzber F; Waeg G; Schaur RJ
Free Radic Biol Med; 1998 May; 24(7-8):1139-48. PubMed ID: 9626568
[TBL] [Abstract][Full Text] [Related]
25. Effect of hypochlorite (HOCl)-modified low density lipoproteins and high density lipoproteins on platelet function.
Opper C; Schüssler G; Sattler W; Malle E
Platelets; 1998; 9(5):339-41. PubMed ID: 16793758
[TBL] [Abstract][Full Text] [Related]
26. Hypochlorous acid-induced lysis of human erythrocytes. Inhibition of cellular damage by the isoflavonoid genistein-8-C-glucoside.
Zavodnik LB; Zavodnik IB; Lapshina EA; Shkodich AP; Bryszewska M; Buko VU
Biochemistry (Mosc); 2000 Aug; 65(8):946-51. PubMed ID: 11002188
[TBL] [Abstract][Full Text] [Related]
27. L-propionyl carnitine protects erythrocytes and low density lipoproteins against peroxidation.
Bertelli A; Conte A; Ronca G
Drugs Exp Clin Res; 1994; 20(5):191-7. PubMed ID: 7875055
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins.
Malle E; Waeg G; Schreiber R; Gröne EF; Sattler W; Gröne HJ
Eur J Biochem; 2000 Jul; 267(14):4495-503. PubMed ID: 10880973
[TBL] [Abstract][Full Text] [Related]
29. Effect of N-chloroamino acids on the erythrocyte.
Robaszkiewicz A; Bartosz G; Soszyński M
Free Radic Res; 2008 Jan; 42(1):30-9. PubMed ID: 18324521
[TBL] [Abstract][Full Text] [Related]
30. Interactions of human blood plasma with hydrogen peroxide and hypochlorous acid.
van der Vliet A; Hu ML; O'Neill CA; Cross CE; Halliwell B
J Lab Clin Med; 1994 Nov; 124(5):701-7. PubMed ID: 7964128
[TBL] [Abstract][Full Text] [Related]
31. Hypochlorous acid impairs endothelium-derived nitric oxide bioactivity through a superoxide-dependent mechanism.
Stocker R; Huang A; Jeranian E; Hou JY; Wu TT; Thomas SR; Keaney JF
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2028-33. PubMed ID: 15331437
[TBL] [Abstract][Full Text] [Related]
32. Hypochlorous acid-mediated oxidation of lipid components and antioxidants present in low-density lipoproteins: absolute rate constants, product analysis, and computational modeling.
Pattison DI; Hawkins CL; Davies MJ
Chem Res Toxicol; 2003 Apr; 16(4):439-49. PubMed ID: 12703960
[TBL] [Abstract][Full Text] [Related]
33. Hypochlorous acid-derived modification of phospholipids: characterization of aminophospholipids as regulatory molecules for lipid peroxidation.
Kawai Y; Kiyokawa H; Kimura Y; Kato Y; Tsuchiya K; Terao J
Biochemistry; 2006 Nov; 45(47):14201-11. PubMed ID: 17115715
[TBL] [Abstract][Full Text] [Related]
34. Isolation, characterization, and functional assessment of oxidatively modified subfractions of circulating low-density lipoproteins.
Yang CY; Raya JL; Chen HH; Chen CH; Abe Y; Pownall HJ; Taylor AA; Smith CV
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1083-90. PubMed ID: 12689919
[TBL] [Abstract][Full Text] [Related]
35. Intracellular oxidative modification of low density lipoprotein by endothelial cells.
Satoh T; Tokunaga O
Virchows Arch; 2002 Apr; 440(4):410-7. PubMed ID: 11956823
[TBL] [Abstract][Full Text] [Related]
36. Phospholipid chlorohydrin induces leukocyte adhesion to ApoE-/- mouse arteries via upregulation of P-selectin.
Dever GJ; Benson R; Wainwright CL; Kennedy S; Spickett CM
Free Radic Biol Med; 2008 Feb; 44(3):452-63. PubMed ID: 18005671
[TBL] [Abstract][Full Text] [Related]
37. Aluminum ions stimulate the oxidizability of low density lipoprotein by Fe2+: implication in hemodialysis mediated atherogenic LDL modification.
Kapiotis S; Hermann M; Exner M; Sturm BN; Scheiber-Mojdehkar B; Goldenberg H; Kopp S; Chiba P; Gmeiner BM
Free Radic Res; 2005 Nov; 39(11):1225-31. PubMed ID: 16298749
[TBL] [Abstract][Full Text] [Related]
38. Taurine modulation of hypochlorous acid-induced lung epithelial cell injury in vitro. Role of anion transport.
Cantin AM
J Clin Invest; 1994 Feb; 93(2):606-14. PubMed ID: 8113398
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of protons and argon ions in initiating lipid peroxidation in low-density lipoproteins.
Ziegler C; Bonnefont-Rousselot D; Delacroix S; Habrand JL; Mazal A
Radiat Res; 1998 Oct; 150(4):483-7. PubMed ID: 9768864
[TBL] [Abstract][Full Text] [Related]
40. The IgM response to modified LDL in experimental atherosclerosis: hypochlorite-modified LDL IgM antibodies versus classical natural T15 IgM antibodies.
van Leeuwen M; Damoiseaux J; Duijvestijn A; Heeringa P; Gijbels M; de Winther M; Tervaert JW
Ann N Y Acad Sci; 2009 Sep; 1173():274-9. PubMed ID: 19758162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
